Fungal infections in bone marrow transplant patients

Area of Science:

• Mycology
• Immunology
• Hematology

Background:

• Invasive fungal infections (IFIs) are the leading infectious cause of mortality in hematopoietic cell transplantation (HCT) recipients.
• Increased incidence of common and emerging fungal pathogens, coupled with high mortality rates, necessitates advanced research.
• A growing arsenal of broad-spectrum antifungal drugs has spurred renewed interest in understanding IFIs.

Purpose of the Study:

• To review primary research on IFIs in HCT recipients from 2003 to the present.
• To synthesize findings on pathogenesis, prevention, diagnosis, and treatment strategies.
• To highlight advancements in understanding and managing IFIs in this vulnerable population.

Main Methods:

• Systematic review of primary research published between 2003 and the present.
• Focus on studies relevant to IFIs in the context of HCT.
• Analysis of themes including antifungal prophylaxis, risk factors, and immune responses.

Main Results:

• Key research themes include antifungal prophylaxis efficacy and tolerability.
• Epidemiologic analyses identified risk factors, particularly after nonmyeloablative preparative regimens.
• Studies provided more detailed insights into nonmyeloid immune responses to fungal infections.

Conclusions:

• While definitive recommendations are limited, recent studies enhance understanding of IFI immunobiology.
• The utility and limitations of newer antifungal agents for prophylaxis and treatment are better defined.
• Ongoing research contributes to improved management strategies for IFIs in HCT.